研究支援発表論文

2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

2016

108. Hasegawa T, Ikeda HO, Nakano N, Muraoka Y, Tsuruyama T, Okamoto-Furuta K, Kohda H, Yoshimura N. Changes in morphology and visual function over time in mouse models of retinal degeneration: an SD-OCT, histology, and electroretinography study. Jpn J Ophthalmol. 60(2): 111-25, 2016

107. Shiokawa M, Kodama Y, Kuriyama K, Yoshimura K, Tomono T, Morita T, Kakiuchi N, Matsumori T, Mima A, Nishikawa Y, Ueda T, Tsuda M, Yamauchi Y, Minami R, Sakuma Y, Ota Y, Maruno T, Kurita A, Sawai Y, Tsuji Y, Uza N, Matsumura K, Watanabe T, Notohara K, Tsuruyama T, Seno H, Chiba T. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016 Mar 10. pii: gutjnl-2015-310336. doi: 10.1136/gutjnl-2015-310336. [Epub ahead of print]

106. Shimizu S, Fujita H, Sasaki Y, Tsuruyama T, Fukuda K, Iwai K. Differential involvement of the NZF domains of SHARPIN and HOIL-1L in LUBAC-mediated cell death protection. Mol Cell Biol. 2016 Mar 14. pii: MCB.01049-15.

105. Nakano N, Ikeda H, Tsuruyama T, Yoshimura N et al. Neuroprotective Effects of VCP Modulators in Mouse Models of Glaucoma. Heliyon. 2016 (in press).

104. Okumura S, Teratani T, Fujimoto Y, Zhao X, Tsuruyama T, Masano Y, Kasahara N, Iida T, Yagi S, Uemura T, Kaido T, Uemoto S. Oral administration of polyamines ameliorates liver ischemia-reperfusion injury and promotes liver regeneration in rats. Liver Transpl. 2016 Apr 21(in press).

103. Ikezoe K, Oga T, Honda T, Hara-Chikuma M, Ma X, Tsuruyama T, Uno K, Fuchikami J, Tanizawa K, Handa T, Taguchi Y, Verkman AS, Narumiya S, Mishima M, Chin K. Aquaporin-3 potentiates ovalbumin-induced murine asthma by mediating both chemokine production in alveolar macrophages and T cell trafficking. Sci Rep. 2016 May 11;6:25781. doi: 10.1038/srep25781. (in press).

↑page top

2015

102. Tsuruyama T, Aini W, Hiratsuka T. Reassessment of H&E-stained clot specimens and immunohistochemistry of phosphorylated Stat5 for histologic diagnosis of MDS/MPN. Pathology Pathology. 2015 Oct 29.

101. Hiratsuka T, Takei Y, Ohmori R, Imai Y, Ozeki M, Tamaki K, Haga H, Nakamura T, Tsuruyama T. ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway. Oncogene 2015 Nov 2.

100. Ueno H, Tsuruyama T, Nowakowskic B, Goreckic J, Yoshikawaa K. Discrimination of time-dependent inflow properties with a cooperative dynamical system. Chaos. 2015 Oct;25(10):103115.

99. Sokai A, Handa T, Tanizawa K, Oga T, Uno K, Tsuruyama T, Kubo T, Ikezoe K, Nakatsuka Y, Tanimura K, Muro S, Hirai T, Nagai S, Chin K, Mishima M. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis. Respiratory Research. Respir Res. 2015 Sep 29;16:120.

98. Miyao M, Kotani H, Ishida T, Kawai C, Manabe S, Abiru H, Tamaki K. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Lab Invest. 2015;95(10):1130-44.

97. Inoue H, Tsuruyama T. Issues Concerning Clinical Research Using Human Pathologic Bioresources in the Biobank Era. Int. J. Forensic and Pathology. 2015. Int J Forensic Sci Pathol. 3(10), 176 176-178.

96. Hamaji M, Kojima F, Koyasu S, Nobashi T, Tsuruyama T, Date H, Nakamura T.A rigid and bioabsorbable material for anterior chest wall reconstruction in a canine model. Interact Cardiovasc Thorac Surg. 2014 Dec 10. 2015 Mar;20(3):322-8.

95. Hiejima E, Tomoki Kawai T, Nakase H, Tsuruyama T, Morimoto T, Yasumi T, Taga T, Kanegane H, Hori M, Ohmori K, Higuchi T, Matsuura M, Takuya Yoshino T, Ikeuchi H, Kawada K, Sakai Y, Kitazume M, Hisamatsu T, Chiba T, Nishikomori R, Heike T.Reduced numbers and proapoptotic features of mucosal-associated invariant T cells as a characteristic finding in IBD patients. 2015. Inflammatory bowel diseases. May 2.

94. Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H. The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion. Cancer Immunol Res. 2015 Mar 3. pii: canimm.0199.2014.

93. Ueshima, Chiyuki; Kataoka, Tatsuki; Hirata, Masahiro; Koyanagi, Itsuko; Honda, Tetsuya; Tsuruyama, Tatsuaki; Okayama, Yoshimichi; Seiyama, Akitoshi; Haga, Hironori.NKp46 regulates the production of serine proteases and IL-22 in human mast cells in urticaria pigmentosaAccepted for publication: 24-Apr-2015 Experimental Dermatology. Production Editor Experimental Dermatology.

92. Ma X, Aoki T, Tsuruyama T, Narumiya S. Definition of prostaglandin E2-EP2 signals in the colon tumor microenvironment which amplify inflammation and tumor growth. Cancer Res. 2015 May 27. pii: canres.0125.

91. Shibasaki N, Yamasaki T, Kanno T, Arakaki R, Sakamoto H, Utsunomiya N, Inoue T, Tsuruyama T, Nakamura E, Ogawa O, Kamba T. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.PLoS One. 2015 Jun 26;10(6):e0130980.

↑page top

2014

90. Endo K, Hori T, Jobara, Hata T, Tsuruyama T, Uemoto S. Pretransplant replacement of donor liver grafts with recipient Kupffer cells attenuates liver graft rejection in rats. Journal of Gastroenterology and Hepatology. 2014. Dec (in print).

89. Hamaji M, Kojima F, Koyasu S, Nobashi T, Tsuruyama T, Date H, Nakamura T.A rigid and bioabsorbable material for anterior chest wall reconstruction in a canine model. Interact Cardiovasc Thorac Surg. 2014 Dec 10. [Epub ahead of print]

88. Tsuruyama T, Kakimoto Y. Forensic diagnosis of Acute Myocardial Infarction: Application of Mass Spectrometry. 2014. Nov12 Int. J. Forensic and Pathology 2(8),1-5.

87. Kakimoto Y, Yajima Y, Tsuruyama T. Application of mass spectrometry for identification of biomarkers in formaldehyde-fixed paraffin embedded specimens. Austin Bioarker and Diagnosis.

86. Tsuruyama T, A model of cell biological signaling predicts the phase transition of signaling and provides mathematical formula of signaling. PLoS One 2014 9(7): e102911.

85. Tsuruyama T, Aini W. The roles of invariant NKT cells in bowel immunity: suppression of tumor progression and rejection of intestinal transplant. 2014 “Immune Response Activation”, book edited by Guy Huynh Thien Duc, ISBN 978-953-51-1374-4, Published: May 29, 2014.

84. Tsuruyama T. Application of Biophysical Approach for Pathological Diagnosis: Mass Spectrometry-Imaging. The 8th IUPAP International Conference on Biological Physics (ICBP2014) , the Institute of Physics, Chinese Academy of Sciences on June 18-22, 2014.

83. Hamaji M, Kojima F, Koyasu S, Tsuruyama T, Komatsu T, Ikuno T, Date H, Nakamura T. Development of a composite and vascularized tracheal scaffold in the omentum for in situ tissue engineering: a canine model. Interact Cardiovasc Thorac Surg. 2014 Jun 3. pii: ivu177. [Epub ahead of print]

82. Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Uehara T, Fujimoto M, Tsuruyama T, Date H, Haga H. : HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations. Lung cancer 2014.

81. Kataoka T, Tsuruyama T Haga H, CD72 negatively regulates mouse mast cell functions by downregulating the expression of KIT and FcεRIα. International Immunology. Int Immunol. 2014 Sep 19. pii: dxu087. [Epub ahead of print]

80. Hamaji M, Kojima F, Komatsu T, Tsuruyama T, Date H, Nakamura T. A synthetic bioabsorbable sheet may prevent postoperative intrapleural adhesions following thoracotomy: a canine model.Interact Cardiovasc Thorac Surg. 2014 Sep 12. pii: ivu299. [Epub ahead of print]

79. Fujisawa M, Udono T, Nogami E, Hirosawa M, Morimura N, Saito A, Seres M, Teramoto M, Nagano K, Mori Y, Uesaka H, Nasu K, Tomonaga M, Idani G, Hirata S, Tsuruyama T, Matsubayashi K. A case of maxillary sarcoma in a chimpan (Pan troglodytes). J Med Primatol. 2014 Apr;43(2):111-4.

78. Ikezoe K, Handa T, Mori K, Watanabe K, Tanizawa K, Aihara K, Tsuruyama T, Miyagawa-Hayashino A, Sokai A, Kubo T, Muro S, Nagai S, Hirai T, Chin K, Mishima M. Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis. Eur Respir J. 2014 Feb 20. [Epub ahead of print]

77. Shinji Sumiyoshi, Akihiko Yoshizawa, Makoto Sonobe, Masashi Kobayashi, Motoki Sato, Masakazu Fujimoto, Tatsuaki Tsuruyama, Hiroshi Date, Hironori Haga. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis. Lung cancer. 2014. Lung Cancer. 2014 Mar 27. pii: S0169-5002(14)00134-2. doi: 10.1016

76. Hamaji M, Kojima F, Koyasu S, Tsuruyama T, Komatsu T, Ikuno T, Date H, Nakamura T. Development of a composite and vascularized tracheal scaffold in the omentum for in situ tissue engineering: a canine model. Interact Cardiovasc Thorac Surg. 2014 Jun 3. pii: ivu177. [Epub ahead of print]

75. Kono F, Honda T, Wramujinag A, Manabe T, Haga H, Tsuruyama T. IFN-γ/CCR5 expression in invariant NKT cells and CCL5 expression in capillary veins of dermal papillae correlate with development of psoriasis vulgaris. Br J Dermatol. 2014 May;170(5):1048-55.

74. 鶴山竜昭、矢島由佳 「質量顕微鏡による単一細胞解析」〜イメージング質量分析の試み〜生体の科学(2014)

↑page top

2013

73. Tsuruyama T, Okamoto S, Fujimoto Y, Yoshizawa A, Yoshitoshi E, Egawa H, Nakase H, Aini W, Miyao M, Tamaki K, Uemoto S, Haga H. Histology of intestinal allografts: lymphocyte apoptosis and phagocytosis of lymphocytic apoptotic bodies are diagnostic findings of acute rejection in addition to crypt apoptosis. American J Surg. Pathol. 2013 Feb;37(2):178-84. Epub 2012Sep 28.

72. Sumiyoshi S, Yoshizawa A, Sonobe M, Kobayashi M, Fujimoto M, Tsuruyama T, Date H, Haga H. Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages. Lung Cancer. 2013 Jul;81(1):53-9.

71. Kataoka T, Kumanogoh A, Hirata M, Moriyoshi K, Ueshima C, Kawahara M, Tsuruyama T, Haga H. CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1. Sci.Rep.2013 Oct 04;3/2861.

70. Kakimoto Y, Ito S, Abiru H, Kotani H, Ozeki M, Tamaki K, Tsuruyama T. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients. J Am Heart Assoc. 2013 Dec 16;2(6):e000565.

69. Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, Tsuruyama T, Travis WD, Date H, Haga H. Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients. J Thorac Oncol. 2013 Jan;8(1):52-61.

68. Tsuruyama T, Nakai T, Ohmori R, Ozeki M, Tamaki K, Yoshikawa K. Dialysis purification of integrase-DNA complexes provides high-resolution atomic force microscopy images: dimeric recombinant HIV-1 integrase binding and specific looping on DNA. PLoS One 2013 Jan; 8(1):e53572.

67. Tsuruyama T, Okamoto S, Fujimoto Y, Yoshizawa A, Yoshitoshi E, Egawa H, Nakase H, Aini W, Miyao M, Tamaki K, Uemoto S, Haga H. Histology of intestinal allografts: lymphocyte apoptosis and phagocytosis of lymphocytic apoptotic bodies are diagnostic findings of acute rejection in addition to crypt apoptosis. American J Surg. Pathol. 2013 Feb;37(2):178-84. Epub 2012Sep 28.

66. Kakimoto Y, Tsuruyama T, Miyao M, Abiru H, Kotani H, Sumiyoshi S, Haga H, Tamaki K. The effectiveness and limitations of triphenyl tetrazolium chloride to detect acute myocardial infarction at forensic autopsy. American Journal of Forensic medicine and Pathology. 2013 (in press).

65. Fujimoto M, Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Koyanagi I, Aini W, Tsuruyama T, Date H, Haga H. Stromal plasma cells expressing immunoglobulin G4 subclass in non- small cell lung cancer. Human Pathology 2013 (in press).

64. Tsuruyama T, Ohmori R. Retroviral integration selectivity. 2013. iConcept press. Introduction to Sequence and Genome Analysis, Retrovirus selective integration, ISBN: 978-14775549-1-3.

63. 鶴山竜昭. 移植小腸の組織像 小児外科 45巻7号(2013年7月号) 特集 ここまで来た小児小腸移植

↑page top

2012

62. Tatsuaki Tsuruyama. HIV-1 selectively integrates into host DNA in vitro ” Biochemistry”, Intech publication, Edited by Deniz Ekinci, pp306-320,2012.

61. Kakimoto Y, Abiru H, Kotani H, Ozeki M, Tsuruyama T, Tamaki K.  Transmesenteric hernia due to double-loop formation in the small intestine: A fatal case involving a toddler. Forensic Sci Int. 2012 Jan 10;214(1-3):e39-42.

60. Tsuruyama T, Liu W, Yoshikawa K. In Vitro Murine Leukemia Retroviral Integration and Structure Fluctuation of Target DNA. PLoS One 2012; 7(2) e31533.

59. Tsuruyama T, Fujimoto Y, Yonekawa Y, Miyao M, Onodera H, Uemoto S, Haga H. Invariant NKT cells infiltrate intestinal allografts undergoing acute cellular rejection. Transplant. Int. 2012 Epub Mar 1.

58. Tsuchiya H, Ikeda Y, Ebata Y, Kojima C, Katsuma R, Tsuruyama T, Sakabe T, Shomori K, Komeda N, Oshiro S, Okamoto H, Takubo K, Hama S, Shudo K, Kogure K, Shiota G. Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice. Hepatology. 2012 Apr 24.

57. Miyao M, Abiru H, Ozeki M, Kotani H, Tusuruyama T, Kobayashi N, Omae T, Osamura T, and Tamaki K. Subdural hemorrhage: A unique case involving vitamin K deficiency bleeding due to biliary atresia. Forensic science international 2012 Forensic Sci Int. 2012 Sep 10;221(1-3):e25-9. Epub 2012 May 16.

56. Yoshitoshi EY, Yoshizawa A, Iwai M, Kaneshiro M, Takada N, Okamoto S, Fujimoto Y, Sakamoto S , Masuda S , Matsuura M , Nakase Y , Tsuruyama T , Haga H , Uemoto S. The Challenge of Acute Rejection in Intestinal Transplantation Pediatr Surg Int. 2012 Aug;28(8):855-9.

55. Aini W, Miyagawa-Hayashino A, Tsuruyama T (Corresponding author), Hashimoto S, Sumiyoshi S, Ozeki M, Tamaki K, Uemoto S, Haga H. Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts. Transplant. Int. Transpl Int. 2012 Sep;25(9):956-66.

54. Kakimoto Y, Tsuruyama T (Corresponding author), Yamamoto T, Furuta M, Ozeki M, Yoshizawa A, Haga H, Keiji Tamaki. Novel in situ Pretreatment Method for Significantly 1 Enhancing the Signal In MALDI-TOF MS of Formalin-fixed Paraffin-embedded Tissue Sections. PLoS One. 2012;7(8):e41607. Epub 2012 Aug 10.

53. Miyao M, Ozeki M, Abiru H, Manabe S, Kotani H, Tsuruyama T, Tamaki K. Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis. Dig Liver Dis. 2012 Oct 26.

52. Ohmori R, Tsuruyama T. In vitro HIV-1 LTR integration into T-cell activation gene CD27 segment and the decoy effect of modified-sequence DNA. PLoS One, 2012 2012;7(11):e49960.

51. Hori M, Nakamachi T, Rakwal R, Shibato J, Ogawa T, Aiuchi T, Tsuruyama T, Tamaki K and Shioda S. Transcriptomics and proteomics analyses of the PACAP38 influenced ischemic brain in permanent middle cerebral artery occlusion model mice. J Neuroinflammation. 2012 Nov 23;9(1):256.

50. Kataoka TR, Fujimoto M, Moriyoshi K, Koyanagi I, Ueshima C, Kono F, Tsuruyama T, Okayama Y, Ra C, Haga H. PD-1 Regulates the Growth of Human Mastocytosis Cells. Allergol Int. 2012 Dec 25.

49. Aini W, Miyagawa-Hayashino A, Ozeki M, Tsuruyama T, Tamaki K, Uemoto S, Haga H. Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome. Transpl Immunol. 2012 Dec 22. doi:pii: S0966-3274(12)00134-7.

48. 鶴山竜昭,日合 弘. モデル動物利用マニュアルシリーズ、疾患モデルの作製と利 用がん第5章造血器第1節 自然発症モデル第2項  SL/Khマウス.エル・アイ・シー, 編集 中村卓郎 (2012)

47. 鶴山竜昭. 小腸移植 病理と臨床 第30巻1号特集「臓器移植の病理」 (2012)

↑page top

2011

46. Tsuruyama T, Hiratsuka T, Jin G, Imai Y, Takeuchi H, Maruyama Y, Kanaya K, Ozeki M, Takakuwa T, Haga H, Tamaki K, Nakamura T.  Murine leukemia retrovirus integration induces the formation of transcription factor complexes on palindromic sequences in the signal transducer and activator of transcription factor 5a gene during the development of pre-B lymphomagenesis. Am J Pathol. 2011 Mar;178(3):1374-86.

45. Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, Negishi K, Tsuruyama T, Uemoto S, Kobayashi E.  Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One. 2011 Apr 29;6(4):e19195.

44. Zhao XD, Fujinaga T, Li Y, Tsuruyama T, Bando T, Wada H, Date H. Prolonged rat kidney preservation with et-kyoto solution: comparison with histidine-tryptophan-ketoglutarate and university of wisconsin solutions.  Transplan Int. 2011; 24 (2) 196-197.

43. Tsuruyama T. In vitro HIV-1 selective integration into the target sequence and decoy-effect of the modified sequence. Retrovirology 2011, 8(Suppl 2).

42. Ohmori R, Saito H, Ikawa Y, Fujita Y, Inoue T. Self-replication reactions dependent on tertiary interaction motifs in an RNA ligase ribozyme. J Mol Evol. 2011 Oct;73(3-4):221-9.

↑page top

2010

41. Kaszynski RH, Akatsuka S, Hiratsuka T, Jin G, Ozeki M, Okuno T, Nakamura T, Manabe T, Takakuwa T, Hiai H, Toyokuni S, Tamaki K, Tsuruyama T. A quantitative trait locus responsible for inducing B-cell lymphoblastic lymphoma is a hotspot for microsatellite instability. Cancer Sci. 2010 Mar;101(3):800-5.

40. Tsuruyama T, Imai Y, Takeuchi H, Hiratsuka T, Maruyama Y, Kanaya K, Kaszynski R, Jin G, Okuno T, Ozeki M, Nakamura T, Takakuwa T, Manabe T, Tamaki K, Hiai H. Dual retrovirus integration tagging: identification of new signaling molecules Fiz1 and Hipk2 that are involved in the IL-7 signaling pathway in B lymphoblastic lymphomas. J Leukoc Biol. 2010 Jul;88(1):107-16.

39. Tsuruyama T, Nakai T, Hiratsuka T, Jin G, Nakamura T, Yoshikawa K. In vitro HIV-1 selective integration into the target sequence and decoy-effect of the modified sequence. PLoS One. 2010 Nov 4;5(11):e13841.

38. 鶴山竜昭. 日本病理学会近畿支部主催病理診断セミナー 病理診断における遺伝子解析の意義 5-24頁(2010)

37. レトロウイルス組込標的核酸 鶴山竜昭 (特許権者 510284783)   登録日2010年11月26日 特許4631084号 広報発行日2011年2月16日

↑page top

2009

36. Okuno T, Ueda M, Tsuruyama T, Haga H, Takada Y, Maetani Y, Tamaki K, Manabe T, Tanaka K, Uemoto S. Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma. Cancer Sci. 2009 Mar;100(3):520-8.

35. Yuan QH, Tanaka A, Kaszynski RH, Iino M, Okuno T, Tsuruyama T, Yamamoto T, Jeffreys AJ, Tamaki K. Minisatellite MS32 alleles show population specificity among Thai, Chinese, and Japanese. J Mol Evol. 2009 Feb;68(2):126-33.

34. Tamaki K, Kaszynski RH, Yuan QH, Yoshida K, Okuno T, Tsuruyama T. Likelihood evaluation using 15 common short tandem repeat loci: a practical and simulated approach to establishing personal identification via sibling/parental assessments.Transfusion. 2009 Mar;49(3):578-84.

33. Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation. 2009 Feb 27;87(4):606-14.

32. Okuno T, Tsuruyama T, Haga H, Ueda M, Takada Y, Maetani Y, Manabe T, Tamaki K.A comparative study of pathological staging systems in predicting recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg. 2009;16(6):802-7.

31. Miyagawa-Hayashino A, Egawa H, Yorifuji T, Hasegawa M, Haga H, Tsuruyama T, Wen MC, Sumazaki R, Manabe T, Uemoto S. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl. 2009 Jun;15(6):610-8.

30. Aoyama A, Chen F, Fujinaga T, Sato A, Tsuruyama T, Zhang J, Shoji T, Sakai H, Nakamura T, Date H, Wada H, Bando T.  Post-ischemic infusion of atrial natriuretic peptide attenuates warm ischemia-reperfusion injury in rat lung. J Heart Lung Transplant. 2009 Jun;28(6):628-34.

29. Fujiwara M, Miayamoto S, Iguchi K, Matsunaka T, Sakashita H, Tsuruyama T, Kanegane H, Marusawa H, Nakase H, Chiba T: Acute Epstein-Barr virus infection presenting as severe gastroenteritis without infectious mononucleosis-like manifestations. Clin J Gastroenterol. 2009;2(6):398-403.

28. Matsumura S, Ohmori R, Saito H, Ikawa Y, Inoue T.

27. Coordinated control of a designed trans-acting ligase ribozyme by a loop-receptor interaction. FEBS Lett. 2009 Sep 3;583(17):2819-26.

26. カシンスキー・リチャード, 鶴山竜昭, 奥野知子, 元慶華, 玉木敬二. リンパ腫好発近交系マウスにおけるマイクロサテライト不安定性の検討 DNA多型17巻 284-285頁 (2009)

↑page top

2008

25. Hiratsuka T, Tsuruyama T, Kaszynski R, Kometani K, Minato N, Nakamura T, Tamaki K, Hiai H. Bone marrow pre-B expansion by SL/Kh-Bomb1 locus: not sufficient for lymphomagenesis. Leuk Res. 2008 Feb;32(2):309-14.

24. Egawa H, Ohdan H, Haga H, Tsuruyama T, Oike F, Uemoto S, Ozawa K. Current status of liver transplantation across ABO blood-type barrier. J Hepatobiliary Pancreat Surg. 2008;15(2):131-8.

23. Zhao X, Koshiba T, Nakamura T, Tsuruyama T, Li Y, Bando T, Wada H, Tanaka K. ET-Kyoto solution plus dibutyryl cyclic adenosine monophosphate is superior to University of Wisconsin solution in rat liver preservation. Cell Transplant. 2008;17(1-2):99-109.

22. Li Y, Zhao X, Cheng D, Haga H, Tsuruyama T, Wood K, Sakaguchi S, Tanaka K, Uemoto S, Koshiba T. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation. 2008 Dec 27;86(12):1837-43.

21. Hironori Haga, Tatsuaki Tsuruyama, Aya Miyagawa. Histopathology in living-donor liver transplantation. Evolution of living donor transplantation. Edited by Koichi Tanaka, Yukihiro Inomata, Shinji Uemoto. Tetsuya Kiuchi. Thomson Reuters, Prous Science pp315-330,2008.

20. カシンスキー・リチャード, 鶴山竜昭, 奥野知子, 元慶華, 飯野守男, 玉木敬二. リンパ腫の責任遺伝子座(Bomb1)におけるマイクロサテライトの不安定性DNA多型16巻 210-211頁 (2008)

↑page top

2007

19. Kotani A, Kakazu N, Tsuruyama T, Okazaki IM, Muramatsu M, Kinoshita K, Nagaoka H, Yabe D, Honjo T. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice. Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1616-20.

18. Iino M, Kimura T, Abiru H, Kaszynski RH, Yuan QH, Tsuruyama T, Tamaki K. Unexpected sudden death resulting from anomalous origin of the right coronary artery from the left sinus of Valsalva: a case report involving identical twins. Leg Med. 2007 Jan;9(1):25-9.

17. Miyagawa-Hayashino A, Tsuruyama T(Coressponding author), Egawa H, Haga H, Sakashita H, Okuno T, Toyokuni S, Tamaki K, Yamabe H, Manabe T, Uemoto S. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol. 2007 Nov;171(5):1499-508.

16. 鶴山竜昭.レトロウイルスゲノム挿入の標的配列日本臨牀 65巻増刊号1 114-117頁 (2007)

15. 李 穎, 趙向東, 成東華, 呉艶玲, 鶴山竜昭, 羽賀博典, 坂口志文, 小柴貴明. Post-Transcriptional Enhancement Of Foxp3 Protein Plays A Key Role Intolerance After Human Liver Transplantation 移植 42巻 327頁 (2007)

↑page top

2006〜以前主なもの

14. Akatsuka S, Aung TT, Dutta KK, Jiang L, Lee WH, Liu YT, Onuki J, Shirase T, Yamasaki K, Ochi H, Naito Y, Yoshikawa T, Kasai H, Tominaga Y, Sakumi K, Nakabeppu Y, Kawai Y, Uchida K, Yamasaki A, Tsuruyama T, Yamada Y, Toyokuni S. Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis. Am J Pathol. 2006 Oct;169(4):1328-42.

13. 鶴山竜昭, 玉木敬二, 平塚拓也, 日合弘. マウス悪性リンパ腫責任遺伝子座の同定. DNA多型14巻172-3頁 (2006)

12. Tanaka Y, Haga H, Egawa H, Okuno T, Miyagawa-Hayashino A, Tsuruyama T, Kambe M, Marusawa H, Chiba T, Manabe T. Intragraft expression of recipient-type ABO blood group antigens: long-term follow-up and histological features after liver transplantation. Liver Transpl. 2005 May;11(5):547-54.

11. Onodera H, Mori A, Nagayama S, Fujimoto A, Tachibana T, Yonenaga Y, Tsuruyama T. Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer. Int J Colorectal Dis. 2005 Nov;20(6):477-84.

10. Tachibana T, Onodera H, Tsuruyama T, Mori A, Nagayama S, Hiai H, Imamura M. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res. 2005 Oct 15;11(20):7322-7.

9. Miyagawa-Hayashino A, Tsuruyama T (Coressponding author), Haga H, Oike F, Il-Deok K, Egawa H, Hiai H, Tanaka K, Manabe T. Arteriopathy in chronic allograft rejection in liver transplantation. Liver Transpl. 2004 Apr;10(4):513-9.

8. Jin G, Tsuruyama T, Yamada Y, Hiai H. Svi3: A provirus common integration site in c-myc in SL/Kh pre-B lymphomas. Cancer Sci. 2003 Sep;94(9):791-5.

7. Hiai H, Tsuruyama T, Yamada Y. Pre-B lymphomas in SL/Kh mice: a multifactorial disease model. Cancer Sci. 2003;94:847-50. Review.

6. Kondo S, Toyokuni S, Tsuruyama T, Ozeki M, Tachibana T, Echizenya M, Hiai H, Onodera H, Imamura M. Peroxynitrite-mediated stress is associated with proliferation of human metastatic colorectal carcinoma in the liver. Cancer Lett. 2002 May 8;179(1):87-93.

5. Tsuruyama T, Nakamura T, Jin G, Ozeki M, Yamada Y, Hiai H. Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8253-8.

4. 羽賀博典, 鶴山竜昭, 尾崎充彦, 井藤久雄. IBD(UCとCrohn病)の病理診断 今, 臨床医は何を生検診断に期待しているか 移植後の腸管の病理学的所見 IBD生検診断との関連 病理と臨床(0287-3745)20巻12号 1268-1273頁 (2002)

3. 鶴山竜昭, 羽賀博典. 臓器移植の病理・小腸移植 移植38巻1号 36-41頁(2002)

2. Fujimoto Y, Uemoto S, Inomata Y, Egawa H, Fujita S, Kawanami T, Tsuruyama T, Hayashi M, Kiuchi T, Asonuma K, Tanaka K.Small bowel transplantation using grafts from living-related donors. Two case reports.Transpl Int. 2000;13 Suppl 1:S179-84.

1. Hiai H, Yamada Y, Abujiang Pataer, Lu L. Kamoyto T, Tsuruyama T. Edited by Hiroshi Hiaim Okio Hino. Genetic and epigenetic susceptibility to endogenous retrovirus-induced lymphomas in SL mice. Animal Models of Cancer Predisposition Syndromes, vol 35, Basel, Karger, pp64-77, 1999.

↑page top